This bill amends Wyoming's Pharmacy Act to raise the minimum age for pharmacists to administer vaccines from 3 to 7 years old, directly affecting children under 7 who previously could receive immunizations from pharmacists. It also adds protections preventing employers from discriminating against pharmacists who decline to provide collaborative pharmacy care or administer vaccines to children under 13. The bill requires the Board of Pharmacy to create rules for collaborative care and vaccine administration, with most provisions taking effect July 1, 2026. These changes clarify pharmacist authority, patient eligibility, and workplace protections under the state's pharmacy regulations.
Wyoming's SF 57, the Hospital Price Transparency Act, requires licensed hospitals to publicly list standard prices for at least 300 "shoppable" medical services (like procedures or supplies patients can schedule in advance) on their websites. Hospitals must display specific charges - including gross charges, discounted cash prices, and negotiated rates - with clear descriptions, in a machine-readable format, and without requiring user accounts or personal information. The Department of Health will monitor compliance and enforce penalties for non-compliance, with hospitals required to update the price lists annually. This directly affects all Wyoming hospitals providing inpatient or outpatient services, aiming to make healthcare pricing more accessible to patients.
This bill updates Wyoming's rules for involuntary mental health treatment. It expands the list of qualified professionals who can conduct initial examinations for individuals needing hospitalization, while requiring a licensed physician or psychologist to review findings if non-physician examiners are used. For outpatient commitment (where patients don't require hospitalization but need supervision), courts must set a maximum two-year period with mandatory court reviews every six months. These changes apply to all Wyoming courts handling mental health commitment cases.
HB 122 establishes Wyoming's program to manage federal rural health transformation funds, creating a permanent "perpetuity fund" to hold and grow these resources. It requires the state to distribute 4% annually from the fund's value (starting July 2026) to support rural health initiatives, with oversight by a 9-member advisory committee appointed by the governor. The bill directly affects rural health providers and communities by governing how federal funds are allocated, invested, and reported. Key mechanisms include mandatory annual fund distributions, committee approval of major expenditures over $500,000, and governance rules for fiscal accountability. This is a procedural framework for managing existing federal funds, not a new service or benefit.
Wyoming's SF 41 creates "portable benefit accounts" to help independent contractors access benefits like health insurance or retirement savings. The bill allows hiring parties (companies or individuals) or contractors themselves to voluntarily contribute funds to these accounts, with strict rules requiring written opt-in agreements and clear disclosure. It prohibits using these contributions to determine employment status and mandates that accounts be managed by approved financial institutions. The law requires the Department of Workforce Services to create implementing rules and takes effect July 1, 2026. This directly affects independent contractors who currently lack employer-provided benefits.
Wyoming's SF 48, the Stem Cell Freedom Act, allows physicians to recommend and perform stem cell therapy using a patient's own cells (autologous mesenchymal stem cells), provided it follows institutional review board approval, current manufacturing standards, and includes written informed consent acknowledging the therapy isn't FDA-approved. The law prohibits the state board of medicine from disciplining doctors for offering this therapy and prevents state entities from denying patient access. It explicitly excludes abortion-derived materials and states insurers may choose but aren't required to cover the therapy. The bill creates no legal liability for providers who follow its requirements and medical standards.
SF 10 allows Wyoming's Department of Health to enter contracts with county detention centers to provide security, examination, and treatment for mentally ill individuals awaiting competency evaluations in criminal cases. This bill directly affects county detention facilities (if designated), the Department of Health, and mentally ill detainees who would be held in these contracted facilities instead of the state hospital. Key provisions include creating new authority for the Department to designate qualified facilities and establish written contracts with counties under Section 7-11-308. The bill amends definitions to explicitly include county jails with such contracts as "facilities" under the law. It takes effect July 1, 2026.
HB 117 requires Wyoming abortion providers to obtain written informed consent before performing an elective abortion, ensuring patients receive complete information about the procedure and alternatives. The bill defines coercion (e.g., threatening job loss, scholarship revocation, or physical harm) as a violation, allowing women harmed by negligent or non-consensual abortions to sue providers. It creates civil liability for providers who fail to verify consent or knowingly perform abortions under coercion. The law applies directly to abortion providers and patients in Wyoming, focusing on preventing coercion through legal accountability.
Wyoming's SF 19 allows schools to stock and administer epinephrine using auto-injectors, nasal sprays, or other FDA-approved devices for severe allergic reactions without requiring a student-specific prescription. It directly affects schools, school nurses, and trained staff by enabling them to provide emergency treatment to students experiencing anaphylaxis. The bill requires schools to develop allergy management guidelines, track incidents, and maintain records of trained personnel, while also providing liability protection for good-faith administration (excluding gross negligence). It updates definitions to include all approved epinephrine delivery methods and specifies that administering stock epinephrine does not constitute the practice of medicine.
The Expanding Physician Access Act allows Wyoming's Board of Medicine to issue provisional medical licenses to internationally trained physicians who meet specific criteria. To qualify, these physicians must have a job offer from a Wyoming health care provider (like a hospital or clinic), hold a current license in their home country for the past five years, complete at least seven years of practice (or 12 years without residency), pass U.S. medical exams and English fluency tests, and have valid U.S. work authorization. The provisional license is tied to employment: if a physician loses their job, the license is suspended until they find new employment, and revoked after six months without a position. A supervising physician - fully licensed in Wyoming with specific qualifications - must be approved to oversee the internationally trained physician.
